Implementation of a comprehensive safer conception intervention for HIV‐serodiscordant couples in Kenya: uptake, use and effectiveness
Introduction Safer conception strategies minimize HIV risk during condomless sex to become pregnant. Gaps remain in understanding the acceptability, feasibility and choices HIV‐serodiscordant couples make when multiple safer conception options are available. Methods We conducted a pilot study of a c...
Gespeichert in:
Veröffentlicht in: | Journal of the International AIDS Society 2019-04, Vol.22 (4), p.e25261-n/a |
---|---|
Hauptverfasser: | , , , , , , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | n/a |
---|---|
container_issue | 4 |
container_start_page | e25261 |
container_title | Journal of the International AIDS Society |
container_volume | 22 |
creator | Heffron, Renee Ngure, Kenneth Velloza, Jennifer Kiptinness, Catherine Quame‐Amalgo, Justice Oluch, Lynda Thuo, Nicholas Njoroge, John Momanyi, Richard Gakuo, Stephen Mbugua, Sarah Morrison, Susan Haugen, Harald Chohan, Bhavna Celum, Connie Baeten, Jared M Mugo, Nelly |
description | Introduction
Safer conception strategies minimize HIV risk during condomless sex to become pregnant. Gaps remain in understanding the acceptability, feasibility and choices HIV‐serodiscordant couples make when multiple safer conception options are available.
Methods
We conducted a pilot study of a comprehensive safer conception package for HIV‐serodiscordant couples with immediate fertility desires in Kenya from March 2016 to April 2018. The intervention package included antiretroviral therapy (ART) for HIV‐positive partners, oral pre‐exposure prophylaxis (PrEP) for HIV‐negative partners, daily fertility and sexual behaviour tracking via short message service (SMS) surveys, counselling on self‐insemination, and referrals for voluntary medical male circumcision and fertility care. Couples attended monthly visits until pregnancy with HIV testing for negative partners at each visit. We estimated the number of expected HIV seroconversions using a counterfactual cohort simulated from gender‐matched couples in the placebo arm of a previous PrEP clinical trial. We used bootstrap methods to compare expected and observed seroconversions.
Results
Of the 74 enrolled couples, 54% were HIV‐negative female/HIV‐positive male couples. The 6 and 12‐month cumulative pregnancy rates were 45.3% and 61.9% respectively. In the month preceding pregnancy, 80.9% of HIV‐positive partners were virally suppressed, 81.4% of HIV‐negative partners were highly adherent to PrEP, and SMS surveys indicated potential timing of condomless sex to peak fertility (median of sex acts = 10, interquartile range (IQR) 7 to 12; median condomless sex acts = 3.5, IQR 1 to 7). Most (95.7%) pregnancies were protected by ≥2 strategies: 57.4% were protected by high PrEP and ART adherence, male circumcision with or without timed condomless sex; 10 (21.3%) were protected by viral suppression in the HIV‐positive partner and male circumcision with or without timed condomless sex; 8 (17.0%) were protected by high PrEP adherence and male circumcision with or without timed condomless sex. We observed 0 HIV seroconversions (95% CI 0.0 to 6.0 per 100 person years), indicating a 100% reduction in HIV risk (p = 0.04).
Conclusions
The use of multiple safer conception strategies, primarily PrEP, ART, male circumcision and/or tracking fertility, was acceptable and feasible for African HIV‐serodiscordant couples and significantly reduced HIV transmission risk. It is important to increase the availability of and counselli |
doi_str_mv | 10.1002/jia2.25261 |
format | Article |
fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6452026</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A586026108</galeid><sourcerecordid>A586026108</sourcerecordid><originalsourceid>FETCH-LOGICAL-c6251-455f7ee8694c69e53eecec31f2dca624b826cd07d7feef25f1df335b0cf63c093</originalsourceid><addsrcrecordid>eNp9ks2O0zAQxyMEYpeFCw-AIiEhhEixndhJOCBVK2ALK3EBrpbrjFuXxA52UtQbR448I0_CdLssLaqQD7bHv_nPhydJHlIyoYSwFyur2IRxJuit5JSWvMqY4Oz23vkkuRfjihDBqqK-m5zkpOZlwchp8mPW9S104AY1WO9Sb1KVat_1AZbgol1DGpWBgDanob9irBsgrNFlezE-pBezz7--_4wQfGOj9qFRbkCHEZUj0ul7cBv1Mh37QX2B5-kYIVWuScEY0AOGcBDj_eSOUW2EB9f7WfLpzeuP5xfZ5Ye3s_PpZaYF4zQrODclQCXqQosaeA6gQefUsEYrwYp5xYRuSNmUBsAwbmhj8pzPiTYi16TOz5JXO91-nHfQaCwjqFb2wXYqbKRXVh6-OLuUC7-WouCMMIECT68Fgv86Qhxkh0VD2yoHfoySMcILSqqqRPTxP-jKj8FheZLlrC55WdfFX2qhWpDWGY9x9VZUTnklMCaqIZUdoRbYO0zSOzAWzQf85AiPq4HO6qMOT_YclqDaYRl9O25_OR6Cz3agDj7GAOameZTI7UDK7UDKq4FE-NF-u2_QPxOIAN0B3zCfzX-k5LvZlO1EfwPCxOyn</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2329757994</pqid></control><display><type>article</type><title>Implementation of a comprehensive safer conception intervention for HIV‐serodiscordant couples in Kenya: uptake, use and effectiveness</title><source>Access via Wiley Online Library</source><source>MEDLINE</source><source>DOAJ Directory of Open Access Journals</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Online Library (Open Access Collection)</source><source>PubMed Central</source><creator>Heffron, Renee ; Ngure, Kenneth ; Velloza, Jennifer ; Kiptinness, Catherine ; Quame‐Amalgo, Justice ; Oluch, Lynda ; Thuo, Nicholas ; Njoroge, John ; Momanyi, Richard ; Gakuo, Stephen ; Mbugua, Sarah ; Morrison, Susan ; Haugen, Harald ; Chohan, Bhavna ; Celum, Connie ; Baeten, Jared M ; Mugo, Nelly</creator><creatorcontrib>Heffron, Renee ; Ngure, Kenneth ; Velloza, Jennifer ; Kiptinness, Catherine ; Quame‐Amalgo, Justice ; Oluch, Lynda ; Thuo, Nicholas ; Njoroge, John ; Momanyi, Richard ; Gakuo, Stephen ; Mbugua, Sarah ; Morrison, Susan ; Haugen, Harald ; Chohan, Bhavna ; Celum, Connie ; Baeten, Jared M ; Mugo, Nelly</creatorcontrib><description>Introduction
Safer conception strategies minimize HIV risk during condomless sex to become pregnant. Gaps remain in understanding the acceptability, feasibility and choices HIV‐serodiscordant couples make when multiple safer conception options are available.
Methods
We conducted a pilot study of a comprehensive safer conception package for HIV‐serodiscordant couples with immediate fertility desires in Kenya from March 2016 to April 2018. The intervention package included antiretroviral therapy (ART) for HIV‐positive partners, oral pre‐exposure prophylaxis (PrEP) for HIV‐negative partners, daily fertility and sexual behaviour tracking via short message service (SMS) surveys, counselling on self‐insemination, and referrals for voluntary medical male circumcision and fertility care. Couples attended monthly visits until pregnancy with HIV testing for negative partners at each visit. We estimated the number of expected HIV seroconversions using a counterfactual cohort simulated from gender‐matched couples in the placebo arm of a previous PrEP clinical trial. We used bootstrap methods to compare expected and observed seroconversions.
Results
Of the 74 enrolled couples, 54% were HIV‐negative female/HIV‐positive male couples. The 6 and 12‐month cumulative pregnancy rates were 45.3% and 61.9% respectively. In the month preceding pregnancy, 80.9% of HIV‐positive partners were virally suppressed, 81.4% of HIV‐negative partners were highly adherent to PrEP, and SMS surveys indicated potential timing of condomless sex to peak fertility (median of sex acts = 10, interquartile range (IQR) 7 to 12; median condomless sex acts = 3.5, IQR 1 to 7). Most (95.7%) pregnancies were protected by ≥2 strategies: 57.4% were protected by high PrEP and ART adherence, male circumcision with or without timed condomless sex; 10 (21.3%) were protected by viral suppression in the HIV‐positive partner and male circumcision with or without timed condomless sex; 8 (17.0%) were protected by high PrEP adherence and male circumcision with or without timed condomless sex. We observed 0 HIV seroconversions (95% CI 0.0 to 6.0 per 100 person years), indicating a 100% reduction in HIV risk (p = 0.04).
Conclusions
The use of multiple safer conception strategies, primarily PrEP, ART, male circumcision and/or tracking fertility, was acceptable and feasible for African HIV‐serodiscordant couples and significantly reduced HIV transmission risk. It is important to increase the availability of and counselling about safer conception services in regions with HIV epidemics involving heterosexual transmission and high fertility.</description><identifier>ISSN: 1758-2652</identifier><identifier>EISSN: 1758-2652</identifier><identifier>DOI: 10.1002/jia2.25261</identifier><identifier>PMID: 30957420</identifier><language>eng</language><publisher>Switzerland: International AIDS Society</publisher><subject>Acquired immune deficiency syndrome ; Adult ; AIDS ; Analysis ; Anti-HIV Agents - administration & dosage ; Antiretroviral drugs ; Conception (Human reproduction) ; Confidence intervals ; Counseling ; Disease prevention ; Disease transmission ; Female ; Fertility ; Fertilization ; Gender ; Health aspects ; HIV ; HIV Infections - drug therapy ; HIV Infections - physiopathology ; HIV Infections - prevention & control ; HIV Infections - psychology ; HIV‐serodiscordant couples ; Human immunodeficiency virus ; Humans ; Infections ; Infertility ; Kenya - epidemiology ; Male ; Medical research ; Medical tests ; Middle Aged ; Pilot Projects ; Population ; Pre-Exposure Prophylaxis - methods ; Pregnancy ; PrEP ; Safe Sex ; safer conception ; Safety and security measures ; Sexual Behavior ; Sexual Partners ; Sperm ; Studies ; Womens health ; Young Adult</subject><ispartof>Journal of the International AIDS Society, 2019-04, Vol.22 (4), p.e25261-n/a</ispartof><rights>2019 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society.</rights><rights>COPYRIGHT 2019 International AIDS Society</rights><rights>2019. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c6251-455f7ee8694c69e53eecec31f2dca624b826cd07d7feef25f1df335b0cf63c093</citedby><cites>FETCH-LOGICAL-c6251-455f7ee8694c69e53eecec31f2dca624b826cd07d7feef25f1df335b0cf63c093</cites><orcidid>0000-0001-6039-0352 ; 0000-0002-8813-3419 ; 0000-0001-8242-8438</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452026/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC6452026/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,315,729,782,786,866,887,1419,11571,27933,27934,45583,45584,46061,46485,53800,53802</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/30957420$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Heffron, Renee</creatorcontrib><creatorcontrib>Ngure, Kenneth</creatorcontrib><creatorcontrib>Velloza, Jennifer</creatorcontrib><creatorcontrib>Kiptinness, Catherine</creatorcontrib><creatorcontrib>Quame‐Amalgo, Justice</creatorcontrib><creatorcontrib>Oluch, Lynda</creatorcontrib><creatorcontrib>Thuo, Nicholas</creatorcontrib><creatorcontrib>Njoroge, John</creatorcontrib><creatorcontrib>Momanyi, Richard</creatorcontrib><creatorcontrib>Gakuo, Stephen</creatorcontrib><creatorcontrib>Mbugua, Sarah</creatorcontrib><creatorcontrib>Morrison, Susan</creatorcontrib><creatorcontrib>Haugen, Harald</creatorcontrib><creatorcontrib>Chohan, Bhavna</creatorcontrib><creatorcontrib>Celum, Connie</creatorcontrib><creatorcontrib>Baeten, Jared M</creatorcontrib><creatorcontrib>Mugo, Nelly</creatorcontrib><title>Implementation of a comprehensive safer conception intervention for HIV‐serodiscordant couples in Kenya: uptake, use and effectiveness</title><title>Journal of the International AIDS Society</title><addtitle>J Int AIDS Soc</addtitle><description>Introduction
Safer conception strategies minimize HIV risk during condomless sex to become pregnant. Gaps remain in understanding the acceptability, feasibility and choices HIV‐serodiscordant couples make when multiple safer conception options are available.
Methods
We conducted a pilot study of a comprehensive safer conception package for HIV‐serodiscordant couples with immediate fertility desires in Kenya from March 2016 to April 2018. The intervention package included antiretroviral therapy (ART) for HIV‐positive partners, oral pre‐exposure prophylaxis (PrEP) for HIV‐negative partners, daily fertility and sexual behaviour tracking via short message service (SMS) surveys, counselling on self‐insemination, and referrals for voluntary medical male circumcision and fertility care. Couples attended monthly visits until pregnancy with HIV testing for negative partners at each visit. We estimated the number of expected HIV seroconversions using a counterfactual cohort simulated from gender‐matched couples in the placebo arm of a previous PrEP clinical trial. We used bootstrap methods to compare expected and observed seroconversions.
Results
Of the 74 enrolled couples, 54% were HIV‐negative female/HIV‐positive male couples. The 6 and 12‐month cumulative pregnancy rates were 45.3% and 61.9% respectively. In the month preceding pregnancy, 80.9% of HIV‐positive partners were virally suppressed, 81.4% of HIV‐negative partners were highly adherent to PrEP, and SMS surveys indicated potential timing of condomless sex to peak fertility (median of sex acts = 10, interquartile range (IQR) 7 to 12; median condomless sex acts = 3.5, IQR 1 to 7). Most (95.7%) pregnancies were protected by ≥2 strategies: 57.4% were protected by high PrEP and ART adherence, male circumcision with or without timed condomless sex; 10 (21.3%) were protected by viral suppression in the HIV‐positive partner and male circumcision with or without timed condomless sex; 8 (17.0%) were protected by high PrEP adherence and male circumcision with or without timed condomless sex. We observed 0 HIV seroconversions (95% CI 0.0 to 6.0 per 100 person years), indicating a 100% reduction in HIV risk (p = 0.04).
Conclusions
The use of multiple safer conception strategies, primarily PrEP, ART, male circumcision and/or tracking fertility, was acceptable and feasible for African HIV‐serodiscordant couples and significantly reduced HIV transmission risk. It is important to increase the availability of and counselling about safer conception services in regions with HIV epidemics involving heterosexual transmission and high fertility.</description><subject>Acquired immune deficiency syndrome</subject><subject>Adult</subject><subject>AIDS</subject><subject>Analysis</subject><subject>Anti-HIV Agents - administration & dosage</subject><subject>Antiretroviral drugs</subject><subject>Conception (Human reproduction)</subject><subject>Confidence intervals</subject><subject>Counseling</subject><subject>Disease prevention</subject><subject>Disease transmission</subject><subject>Female</subject><subject>Fertility</subject><subject>Fertilization</subject><subject>Gender</subject><subject>Health aspects</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>HIV Infections - physiopathology</subject><subject>HIV Infections - prevention & control</subject><subject>HIV Infections - psychology</subject><subject>HIV‐serodiscordant couples</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infections</subject><subject>Infertility</subject><subject>Kenya - epidemiology</subject><subject>Male</subject><subject>Medical research</subject><subject>Medical tests</subject><subject>Middle Aged</subject><subject>Pilot Projects</subject><subject>Population</subject><subject>Pre-Exposure Prophylaxis - methods</subject><subject>Pregnancy</subject><subject>PrEP</subject><subject>Safe Sex</subject><subject>safer conception</subject><subject>Safety and security measures</subject><subject>Sexual Behavior</subject><subject>Sexual Partners</subject><subject>Sperm</subject><subject>Studies</subject><subject>Womens health</subject><subject>Young Adult</subject><issn>1758-2652</issn><issn>1758-2652</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2019</creationdate><recordtype>article</recordtype><sourceid>24P</sourceid><sourceid>WIN</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><recordid>eNp9ks2O0zAQxyMEYpeFCw-AIiEhhEixndhJOCBVK2ALK3EBrpbrjFuXxA52UtQbR448I0_CdLssLaqQD7bHv_nPhydJHlIyoYSwFyur2IRxJuit5JSWvMqY4Oz23vkkuRfjihDBqqK-m5zkpOZlwchp8mPW9S104AY1WO9Sb1KVat_1AZbgol1DGpWBgDanob9irBsgrNFlezE-pBezz7--_4wQfGOj9qFRbkCHEZUj0ul7cBv1Mh37QX2B5-kYIVWuScEY0AOGcBDj_eSOUW2EB9f7WfLpzeuP5xfZ5Ye3s_PpZaYF4zQrODclQCXqQosaeA6gQefUsEYrwYp5xYRuSNmUBsAwbmhj8pzPiTYi16TOz5JXO91-nHfQaCwjqFb2wXYqbKRXVh6-OLuUC7-WouCMMIECT68Fgv86Qhxkh0VD2yoHfoySMcILSqqqRPTxP-jKj8FheZLlrC55WdfFX2qhWpDWGY9x9VZUTnklMCaqIZUdoRbYO0zSOzAWzQf85AiPq4HO6qMOT_YclqDaYRl9O25_OR6Cz3agDj7GAOameZTI7UDK7UDKq4FE-NF-u2_QPxOIAN0B3zCfzX-k5LvZlO1EfwPCxOyn</recordid><startdate>201904</startdate><enddate>201904</enddate><creator>Heffron, Renee</creator><creator>Ngure, Kenneth</creator><creator>Velloza, Jennifer</creator><creator>Kiptinness, Catherine</creator><creator>Quame‐Amalgo, Justice</creator><creator>Oluch, Lynda</creator><creator>Thuo, Nicholas</creator><creator>Njoroge, John</creator><creator>Momanyi, Richard</creator><creator>Gakuo, Stephen</creator><creator>Mbugua, Sarah</creator><creator>Morrison, Susan</creator><creator>Haugen, Harald</creator><creator>Chohan, Bhavna</creator><creator>Celum, Connie</creator><creator>Baeten, Jared M</creator><creator>Mugo, Nelly</creator><general>International AIDS Society</general><general>John Wiley & Sons, Inc</general><general>John Wiley and Sons Inc</general><scope>24P</scope><scope>WIN</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9.</scope><scope>M0S</scope><scope>M1P</scope><scope>PIMPY</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>7X8</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0001-6039-0352</orcidid><orcidid>https://orcid.org/0000-0002-8813-3419</orcidid><orcidid>https://orcid.org/0000-0001-8242-8438</orcidid></search><sort><creationdate>201904</creationdate><title>Implementation of a comprehensive safer conception intervention for HIV‐serodiscordant couples in Kenya: uptake, use and effectiveness</title><author>Heffron, Renee ; Ngure, Kenneth ; Velloza, Jennifer ; Kiptinness, Catherine ; Quame‐Amalgo, Justice ; Oluch, Lynda ; Thuo, Nicholas ; Njoroge, John ; Momanyi, Richard ; Gakuo, Stephen ; Mbugua, Sarah ; Morrison, Susan ; Haugen, Harald ; Chohan, Bhavna ; Celum, Connie ; Baeten, Jared M ; Mugo, Nelly</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c6251-455f7ee8694c69e53eecec31f2dca624b826cd07d7feef25f1df335b0cf63c093</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2019</creationdate><topic>Acquired immune deficiency syndrome</topic><topic>Adult</topic><topic>AIDS</topic><topic>Analysis</topic><topic>Anti-HIV Agents - administration & dosage</topic><topic>Antiretroviral drugs</topic><topic>Conception (Human reproduction)</topic><topic>Confidence intervals</topic><topic>Counseling</topic><topic>Disease prevention</topic><topic>Disease transmission</topic><topic>Female</topic><topic>Fertility</topic><topic>Fertilization</topic><topic>Gender</topic><topic>Health aspects</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>HIV Infections - physiopathology</topic><topic>HIV Infections - prevention & control</topic><topic>HIV Infections - psychology</topic><topic>HIV‐serodiscordant couples</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infections</topic><topic>Infertility</topic><topic>Kenya - epidemiology</topic><topic>Male</topic><topic>Medical research</topic><topic>Medical tests</topic><topic>Middle Aged</topic><topic>Pilot Projects</topic><topic>Population</topic><topic>Pre-Exposure Prophylaxis - methods</topic><topic>Pregnancy</topic><topic>PrEP</topic><topic>Safe Sex</topic><topic>safer conception</topic><topic>Safety and security measures</topic><topic>Sexual Behavior</topic><topic>Sexual Partners</topic><topic>Sperm</topic><topic>Studies</topic><topic>Womens health</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Heffron, Renee</creatorcontrib><creatorcontrib>Ngure, Kenneth</creatorcontrib><creatorcontrib>Velloza, Jennifer</creatorcontrib><creatorcontrib>Kiptinness, Catherine</creatorcontrib><creatorcontrib>Quame‐Amalgo, Justice</creatorcontrib><creatorcontrib>Oluch, Lynda</creatorcontrib><creatorcontrib>Thuo, Nicholas</creatorcontrib><creatorcontrib>Njoroge, John</creatorcontrib><creatorcontrib>Momanyi, Richard</creatorcontrib><creatorcontrib>Gakuo, Stephen</creatorcontrib><creatorcontrib>Mbugua, Sarah</creatorcontrib><creatorcontrib>Morrison, Susan</creatorcontrib><creatorcontrib>Haugen, Harald</creatorcontrib><creatorcontrib>Chohan, Bhavna</creatorcontrib><creatorcontrib>Celum, Connie</creatorcontrib><creatorcontrib>Baeten, Jared M</creatorcontrib><creatorcontrib>Mugo, Nelly</creatorcontrib><collection>Wiley Online Library (Open Access Collection)</collection><collection>Wiley Online Library (Open Access Collection)</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Access via ProQuest (Open Access)</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of the International AIDS Society</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Heffron, Renee</au><au>Ngure, Kenneth</au><au>Velloza, Jennifer</au><au>Kiptinness, Catherine</au><au>Quame‐Amalgo, Justice</au><au>Oluch, Lynda</au><au>Thuo, Nicholas</au><au>Njoroge, John</au><au>Momanyi, Richard</au><au>Gakuo, Stephen</au><au>Mbugua, Sarah</au><au>Morrison, Susan</au><au>Haugen, Harald</au><au>Chohan, Bhavna</au><au>Celum, Connie</au><au>Baeten, Jared M</au><au>Mugo, Nelly</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Implementation of a comprehensive safer conception intervention for HIV‐serodiscordant couples in Kenya: uptake, use and effectiveness</atitle><jtitle>Journal of the International AIDS Society</jtitle><addtitle>J Int AIDS Soc</addtitle><date>2019-04</date><risdate>2019</risdate><volume>22</volume><issue>4</issue><spage>e25261</spage><epage>n/a</epage><pages>e25261-n/a</pages><issn>1758-2652</issn><eissn>1758-2652</eissn><abstract>Introduction
Safer conception strategies minimize HIV risk during condomless sex to become pregnant. Gaps remain in understanding the acceptability, feasibility and choices HIV‐serodiscordant couples make when multiple safer conception options are available.
Methods
We conducted a pilot study of a comprehensive safer conception package for HIV‐serodiscordant couples with immediate fertility desires in Kenya from March 2016 to April 2018. The intervention package included antiretroviral therapy (ART) for HIV‐positive partners, oral pre‐exposure prophylaxis (PrEP) for HIV‐negative partners, daily fertility and sexual behaviour tracking via short message service (SMS) surveys, counselling on self‐insemination, and referrals for voluntary medical male circumcision and fertility care. Couples attended monthly visits until pregnancy with HIV testing for negative partners at each visit. We estimated the number of expected HIV seroconversions using a counterfactual cohort simulated from gender‐matched couples in the placebo arm of a previous PrEP clinical trial. We used bootstrap methods to compare expected and observed seroconversions.
Results
Of the 74 enrolled couples, 54% were HIV‐negative female/HIV‐positive male couples. The 6 and 12‐month cumulative pregnancy rates were 45.3% and 61.9% respectively. In the month preceding pregnancy, 80.9% of HIV‐positive partners were virally suppressed, 81.4% of HIV‐negative partners were highly adherent to PrEP, and SMS surveys indicated potential timing of condomless sex to peak fertility (median of sex acts = 10, interquartile range (IQR) 7 to 12; median condomless sex acts = 3.5, IQR 1 to 7). Most (95.7%) pregnancies were protected by ≥2 strategies: 57.4% were protected by high PrEP and ART adherence, male circumcision with or without timed condomless sex; 10 (21.3%) were protected by viral suppression in the HIV‐positive partner and male circumcision with or without timed condomless sex; 8 (17.0%) were protected by high PrEP adherence and male circumcision with or without timed condomless sex. We observed 0 HIV seroconversions (95% CI 0.0 to 6.0 per 100 person years), indicating a 100% reduction in HIV risk (p = 0.04).
Conclusions
The use of multiple safer conception strategies, primarily PrEP, ART, male circumcision and/or tracking fertility, was acceptable and feasible for African HIV‐serodiscordant couples and significantly reduced HIV transmission risk. It is important to increase the availability of and counselling about safer conception services in regions with HIV epidemics involving heterosexual transmission and high fertility.</abstract><cop>Switzerland</cop><pub>International AIDS Society</pub><pmid>30957420</pmid><doi>10.1002/jia2.25261</doi><tpages>10</tpages><orcidid>https://orcid.org/0000-0001-6039-0352</orcidid><orcidid>https://orcid.org/0000-0002-8813-3419</orcidid><orcidid>https://orcid.org/0000-0001-8242-8438</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1758-2652 |
ispartof | Journal of the International AIDS Society, 2019-04, Vol.22 (4), p.e25261-n/a |
issn | 1758-2652 1758-2652 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6452026 |
source | Access via Wiley Online Library; MEDLINE; DOAJ Directory of Open Access Journals; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Online Library (Open Access Collection); PubMed Central |
subjects | Acquired immune deficiency syndrome Adult AIDS Analysis Anti-HIV Agents - administration & dosage Antiretroviral drugs Conception (Human reproduction) Confidence intervals Counseling Disease prevention Disease transmission Female Fertility Fertilization Gender Health aspects HIV HIV Infections - drug therapy HIV Infections - physiopathology HIV Infections - prevention & control HIV Infections - psychology HIV‐serodiscordant couples Human immunodeficiency virus Humans Infections Infertility Kenya - epidemiology Male Medical research Medical tests Middle Aged Pilot Projects Population Pre-Exposure Prophylaxis - methods Pregnancy PrEP Safe Sex safer conception Safety and security measures Sexual Behavior Sexual Partners Sperm Studies Womens health Young Adult |
title | Implementation of a comprehensive safer conception intervention for HIV‐serodiscordant couples in Kenya: uptake, use and effectiveness |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-11-30T13%3A37%3A07IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Implementation%20of%20a%20comprehensive%20safer%20conception%20intervention%20for%20HIV%E2%80%90serodiscordant%20couples%20in%20Kenya:%20uptake,%20use%20and%20effectiveness&rft.jtitle=Journal%20of%20the%20International%20AIDS%20Society&rft.au=Heffron,%20Renee&rft.date=2019-04&rft.volume=22&rft.issue=4&rft.spage=e25261&rft.epage=n/a&rft.pages=e25261-n/a&rft.issn=1758-2652&rft.eissn=1758-2652&rft_id=info:doi/10.1002/jia2.25261&rft_dat=%3Cgale_pubme%3EA586026108%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2329757994&rft_id=info:pmid/30957420&rft_galeid=A586026108&rfr_iscdi=true |